Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-023203

President, R&D sold 18,000 shares at $30.32 ($545,760)

  • President, R&D acquired 18,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bergstrom Donald A · President, R&D

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-04-01 Exercise or conversion : show line 1 in the form +18,000 $4.12 $74,160 112,304 D
2022-04-01 Sale : show line 2 in the form −18,000 $30.32 $545,760 94,304 D
Open-market sales · 18,000 sh · avg $30.32 · $545,760

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-01 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −18,000 199,456 D
Loading xslF345X03/doc4.xml…